Core mega-cap holding.
What happenedPart of the position sold to cut single-name concentration; the rest is retained.
Corevia is an independent research practice, deliberately kept small. The work is done in full and shown in full — the model, the assumptions, and the positions that did not work out. The edge is not better information; it is reading what is already public properly.
A small coverage list, revisited every quarter. Names are added on evidence, not on news flow.
Every rating carries the numbers behind it. Members see the valuation work, not just the conclusion.
Sizing and invalidation come before price targets. What breaks it is asked before what it could be worth.
Every closed position goes on the record. A published loss with a lesson beats a quiet one.
If we hold something we cover, it is disclosed at the top of the report, not buried at the bottom.
No affiliate links, no sponsored coverage. Subscriptions are the only incentive.
Open positions, marked to the last price. Unrealised — a gain is not a result until it is taken.
Prices as of 18 Aug 2026. Unrealised, marked to last price. Position sizes are not shown.
Wins and losses in full. Losses are marked as clearly as wins — a track record without visible losses is not a track record.
Core mega-cap holding.
What happenedPart of the position sold to cut single-name concentration; the rest is retained.
Core AI-compute holding.
What happenedClosed after a 70% gain; proceeds rotated into other positions.
Core mega-cap holding.
What happenedPart of the position sold; the remainder is retained.
Large-cap healthcare position built in January.
What happenedPart of the position sold; the remainder is retained.
Strongest capital position of the group and the most conservative provisioning — the low-risk expression of the same thesis.
What happenedLagged the more discounted names, as a lower-risk holding in a re-rating should. Deliberately owned alongside them rather than instead of them.
Index exposure held alongside the single names, so the book captured the broad re-rating and not only the selection.
What happenedReturned less than the best single names and more than the weakest — which is the entire purpose of holding it, and the benchmark for whether selection added anything.
Building-materials demand from the infrastructure cycle, with US exposure hedging domestic execution risk.
What happenedUnderperformed the basket. The US business carried it while domestic volumes arrived later than expected — the hedge worked, the timing assumption did not.
The defensive leg — emerging-market volume growth with pricing power, held to temper the cyclicality elsewhere.
What happenedThe weakest return in the book and the one that did its job. In a basket this concentrated in domestic cyclicals, something has to be uncorrelated.
Short-term momentum entry on an electrified-powertrain name.
What happenedCut the next session when the move failed to follow through. Small size, stop respected, no thesis creep — the discipline worked even though the trade did not.
Modelled, not live capital. Past results do not indicate future outcomes. Full disclaimer.
The Corevia Discord is where the research comes to life — discussion, debate, live Q&A, and a steady stream of educational material.
There are three ways to take part. Start with the open community, upgrade for the full research desk, or take it all the way with one-to-one work alongside it.
Step in, see how Corevia works, and join the public conversation.
Every paid channel, every tool, every report — the working environment of a Corevia member.
Everything in Standard, plus one-to-one work and the deeper materials I keep for clients.
Every Standard or Full membership starts with a short call — so we can talk about what you’re working on before anything else. Research & education only — no personalised advice.